Isochem launches re-engineered website
Press Release | ISOCHEM S.A.S.
JUNE 06, 2016
The new site at www.isochem.eu provides a complete guide to the French-based CMO’s background, technologies, services and products, along with more intuitive interface and easier browsing.
The Isochem site is also designed to be mobile-friendly, allowing easy browsing from smartphones and tablets.
“This has been a comprehensive upgrade,” said Yves Robin, Isochem’s Vice-President for R&D, Industrialization and Communication.
The site provides direct access to company background, facts and figures, services, products and technologies with faster browsing via drop down menus as well as contextual browsing. It also features new house colors with greater use of graphics, imagery and Flash animation. These are particularly useful in presenting Isochem’s core technologies of phosgenation, hydrogenation, halogenation, cryogenic chemistry and distillation.
“For our customers, we can now offer direct access and navigation from any screen along with clearer and faster information,” said Mr. Robin.
The site provides full information on Isochem’s wide range of products, including generic APIs, Intermediates, NCA – and UNCA N-Carboxyanhydrides, Vitamin E TPGS and anti-scratch varnishes, along with latest news about the company.
“As a result we can be very proud as we have reached our objective of satisfying our customers’ needs,” concluded Yves Robin.
Isochem S.A.S. is a contract manufacturer with a century-old heritage in fine chemistry and a 40-year track record in providing high quality fine chemicals, API building blocks and high value molecules, as well as mastering complex processes. The company can manufacture products and provide services to the most recent and stringent pharmaceutical regulatory standards.
Isochem serves a broad range of customers in many application fields, from leading global companies to virtual and emerging organizations, offering services in three pharma-related fields: custom synthesis, high technology manufacturing in multi-step chemical synthesis including the safe implementation of hazardous reactions, and direct supply of more than 2,300 specific compounds and products, including phosgene derivatives, regulated and non-regulated intermediates and active ingredients.
Isochem can also provide attractive synthetic tools such as activated aminoacids building blocks (N-CarboxyAnhydride NCA) used in peptide chemistry. It is also expert in process optimization from pre-clinical development to full-scale production.
Isochem is now an international company with some 350 employees worldwide. The Head office is located near Paris, in Vert-Le-Petit, France, on one of Isochem’s five manufacturing sites. The company is a wholly owned subsidiary of Munich-based Aurelius AG.
Yves Robin, VP R&D and Industrialization, Isochem S.A.S.
Tel: +33 1 64 99 05 49